NCT04543188 2025-10-23
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
Pfizer
Phase 1 Terminated
Clinical Trials
5 trialsNCT01296555 2024-07-31
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Genentech, Inc.
Phase 1 Terminated
NCT03043430 2023-04-25
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Brooke Army Medical Center
Phase 4 Terminated
NCT02244112 2021-02-21
A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies
Amgen
Phase 1 Terminated
NCT02317341 2019-03-20
Effect of Ketamine on Fatigue Following Cancer Therapy
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated